Alzheimer's Drug Trials Should Report Effect Sizes, Researchers Say

(MedPage Today) -- Standard effect sizes are more meaningful outcomes in Alzheimer's disease drug trials than the widely used metric of percent slowing of decline, an analysis suggested.
In recent trials of Alzheimer's anti-amyloid agents, effect...

Source: MedPage Today Psychiatry - November 22, 2023 Category: Psychiatry Source Type: news